Skip to main content

The Government has been Very Supportive on e-Pharmacies

The Government has been Very Supportive on e-Pharmacies
The online pharmacy sector expects regulations to be streamlined by the end of this year, Prashant Tandon, CEO of 1mg and president of the India Internet Pharmacy Association, said in an interview. Edited excerpts:
How has regulation been a pain for e-pharmacy startups? In the last two years, many epharmacies had to shut because they were harassed by the local players. When a drug inspector comes to a vendor he knows only the Drugs and Cosmetics Act. We need to see it in light of the IT Act, which supersedes all other acts in terms of applicability. What we have been asking is that since the IT Act supersedes all other Acts in terms of applicability, all of that needs to be harmonised and communicated though one notification.
On that, the government has taken a very positive stance on that but hasn’t yet introduced any notification. We have been assured that work is in progress towards that. But the local harassment has reduced.What about your demand to be treated at par with offline pharmacies? There are a lot of laws in the Drugs and Cosmetics Act that we comply with but (in reality) these don’t apply to offline pharmacies, which continue to dispense medicines without prescriptions. The law should be uniformly applicable across the board. It should not be the case that because we are following the law
we lose business. What are your main demands? Harmonise all major applicable laws and Acts—definition of marketplaces as per DIPP, the Drugs and Cosmetics Act, and the IT Act. The Drugs and Cosmetics Act needs to be updated so that it is implementable in the online world. We are also demanding that the government mandate the registry of all e-pharmacies. What the US and Europe have done is that only those e-pharmacies that have registered in the country are allowed to sell within the country. We have asked for a similar thing.Also, things like taking a relook at the classification of medicines. Many medicines are under no schedule.
What headway have you achieved? We are in active conversations with multiple departments of the government, including the health ministry, the IT ministry and DIPP. We have been assured that by the end of this year everything will be streamlined. What we have been asking has been accepted in principle at least.The government has been very proactive and supportive. In the Niti Aayog’s three-year road map, e-pharmacy finds mention as something to be clarified by the end of this year. The draft pharmaceutical policy also validates e-phamacy.
How have the regulatory roadblocks hampered growth plans? Initially, it was proposed that epharmacies should have a physical presence in the states they operate in. We have reservations against that proposal. Interstate restrictions defeat a lot of value for customers. We are in almost 600 cities. As of today, we do not do interstate shipments. But that is a value that e-pharmacies can provide. In every state (we operate in) we make shipments through multiple partners
The Mint, New Delhi, 17th October 2017

Comments

Popular posts from this blog

Govt’s gamble on GST cuts: What do the bond and currency markets signal?

  It’s not just humans who suffer from cognitive biases; markets do too. Interestingly, different financial markets exhibit distinct biases, each interpreting events through its own prism of prejudice. Take the recent announcements on GST reforms: equity markets have chosen to view them through the lens of growth, while bond and currency markets are focusing on potential macroeconomic risks—fiscal pressures and current account challenges. So, which lens captures the true pulse?Equity markets may be right in expecting GST reforms to revive consumption, which has remained lacklustre for a while. But the key question remains—will this revival come at the cost of broader macro stability?It is well known that consumption stocks have rallied since the GST rationalisation announcement. But what about bond markets? What signals are they sending since this rejig was announced from the ramparts of the Red Fort?The signs aren't encouraging. Bond prices have slumped and yields have surged sinc...

Luxury carmakers urge clarity on GST rates to boost festive season sales

  A clear picture regarding new GST rates at the earliest will help the overall auto industry, including the luxury car segment, to regain momentum in the ongoing quarter, which generally sees enhanced sales on account of the festive season.The high-powered GST Council, chaired by Finance Minister Nirmala Sitharaman, will meet on September 3-4 to discuss moving to a two-slab taxation.In an interaction with PTI, BMW Group India President and CEO Hardeep Singh Brar said the recent speculation about the change in GST rates has caused uncertainty in the minds of consumers.Consumer interest and demand is strong, but they (prospective buyers) have adopted a wait-and-watch approach, and this delayed decision-making is impacting new vehicle sales at a certain level, he noted."Expediting clarity on GST rates is essential to get back to speed and ensure the auto sector's contribution to economic growth during this quarter is robust," Brar stated.He also hoped that the sustainable p...

Sebi proposes tighter norms for green bond third-party reviewers

  Sebi on Friday said it has proposed to tighten the norms to appoint independent third-party reviewers or certifiers for green debt securities to align them with requirements for other ESG-linked bonds.In a draft circular, Sebi said that the current norms for green bonds, introduced in February 2023, lack detailed requirements around reviewer independence, conflict of interest mitigation, and disclosure standards that are now in place for other ESG-linked securities under a June 2025 circular.The regulator's latest proposal seeks public comments on a revised framework that would bring parity by incorporating comprehensive criteria for third-party certifiers of green bonds on non-convertible securities.Under the proposed norms, issuers of green debt securities will need to appoint reviewers who are independent of their management, directors, and key managerial personnel. These reviewers will be remunerated in a way that prevents any conflicts of interest and possess relevant expert...